Division of Infection and Immunity, University College London, London, United Kingdom; Cancer Institute, University College London, London, United Kingdom
Matthew Harries
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; Salford Royal NHS Foundation Trust (Dermatology Centre), Salford, United Kingdom
Kate Wicks
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
Theres Oakes
Division of Infection and Immunity, University College London, London, United Kingdom
Helen Singleton
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
Rebecca Dearman
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom
Gavin Maxwell
Safety and Environmental Assurance Centre, Unilever, Colworth Science Park, Bedford, United Kingdom
Division of Infection and Immunity, University College London, London, United Kingdom; Department of Computer Science, University College London, London, United Kingdom
Diphenylcyclopropenone (DPC) is an organic chemical hapten which induces allergic contact dermatitis and is used in the treatment of warts, melanoma, and alopecia areata. This therapeutic setting therefore provided an opportunity to study T cell receptor (TCR) repertoire changes in response to hapten sensitization in humans. Repeated exposure to DPC induced highly dynamic transient expansions of a polyclonal diverse T cell population. The number of TCRs expanded early after sensitization varies between individuals and predicts the magnitude of the allergic reaction. The expanded TCRs show preferential TCR V and J gene usage and consist of clusters of TCRs with similar sequences, two characteristic features of antigen-driven responses. The expanded TCRs share subtle sequence motifs that can be captured using a dynamic Bayesian network. These observations suggest the response to DPC is mediated by a polyclonal population of T cells recognizing a small number of dominant antigens.